2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T5a32,

Summary Table

Feature	Detail
Risk Factors	Post-term pregnancy (>42 weeks), fetal distress, intrauterine growth restriction (IUGR), oligohydramnios, placental insufficiency, maternal hypertension/preeclampsia, cord compression
Etiology	Aspiration of meconium-stained amniotic fluid (MSAF) into the fetal/neonatal tracheobronchial tree, triggered by in-utero hypoxic stress
Patient Presentation	Newborn delivered through meconium-stained amniotic fluid with immediate respiratory distress: tachypnea, grunting, nasal flaring, intercostal retractions
Classic Physical Exam	Yellow-green staining of skin, nails, and umbilical cord; barrel-shaped (hyperexpanded) chest; coarse crackles and rhonchi bilaterally; cyanosis in severe cases
Key Diagnostic Results	CXR: coarse, patchy bilateral infiltrates with hyperinflation and flattened diaphragms; ABG: hypoxemia with respiratory or mixed acidosis; pre/post-ductal SpO2 gradient >5% if PPHN develops
Management	Supportive respiratory care (supplemental O2, mechanical ventilation if needed), surfactant replacement for severe disease, inhaled nitric oxide (iNO) for PPHN, ECMO as last resort; routine tracheal suctioning is no longer recommended
Keywords	"Post-term infant," "meconium-stained fluid," "barrel chest," "patchy infiltrates with hyperinflation," "ball-valve mechanism," "green-stained nails"

1. Pathophysiology

Meconium is the first intestinal discharge of the neonate, composed of swallowed amniotic fluid, bile acids, pancreatic enzymes, mucus, cellular debris, and lanugo. Under normal conditions, meconium is passed after birth. However, when a fetus experiences hypoxic stress, a vagal reflex is triggered that causes relaxation of the anal sphincter and simultaneous stimulation of intestinal peristalsis. This leads to passage of meconium into the amniotic fluid while still in utero. The same hypoxic insult often triggers fetal gasping movements, which draws meconium-contaminated fluid deep into the tracheobronchial tree.

The presence of meconium in the airways causes disease through four interconnected mechanisms. First, the thick, viscous meconium creates partial mechanical airway obstruction via a ball-valve effect: air enters the distal airways during inspiration but cannot fully escape during expiration, leading to progressive air trapping and hyperinflation. This explains the barrel-shaped chest and the increased risk of air leak syndromes such as pneumothorax. Complete obstruction of smaller airways causes distal atelectasis, creating a heterogeneous pattern of hyperinflation and collapse throughout the lung.

Second, the bile acids and pancreatic enzymes within meconium trigger a chemical pneumonitis, causing direct injury to the airway epithelium and alveolar lining. This inflammatory response leads to edema, hemorrhage, and necrosis of the pulmonary tissue. Third, meconium inactivates and displaces surfactant, increasing alveolar surface tension and promoting further atelectasis. This is why exogenous surfactant therapy plays a role in management. Fourth, the combined effects of hypoxia, acidosis, and pulmonary inflammation cause pulmonary arteriolar vasoconstriction, which can progress to persistent pulmonary hypertension of the newborn (PPHN). PPHN creates right-to-left shunting across the patent ductus arteriosus and foramen ovale, worsening systemic hypoxemia and establishing a vicious cycle.

It is also important to recognize that meconium serves as a bacterial growth medium, predisposing the neonate to secondary bacterial pneumonia, which is why empirical antibiotics are frequently administered.

2. Classification and Clinical Manifestation

MAS is classified by severity, which determines the intensity of respiratory support required.

Severity	FiO2 Requirement	Duration	Ventilatory Support	Associated Complications
Mild	<40%	<48 hours	Supplemental O2 by hood or nasal cannula only	Unlikely
Moderate	>40%	>48 hours	May require CPAP or conventional mechanical ventilation	Possible air leak
Severe	High FiO2, often 100%	Prolonged	Requires mechanical ventilation (conventional or high-frequency)	PPHN, pneumothorax, need for iNO or ECMO

Clinical Features by System

System	Findings
General appearance	Postmature features: peeling skin, long nails, reduced vernix; yellow-green meconium staining of skin, nails, umbilical cord
Respiratory	Tachypnea (RR >60/min), grunting, nasal flaring, subcostal and intercostal retractions; barrel-shaped chest due to air trapping
Auscultation	Coarse bilateral crackles, rhonchi; diminished breath sounds in areas of atelectasis or pneumothorax
Cardiovascular	Cyanosis refractory to supplemental oxygen (suggests PPHN); differential cyanosis with pre-ductal SpO2 higher than post-ductal SpO2
Neurologic	May show signs of hypoxic-ischemic encephalopathy (poor tone, depressed reflexes, seizures) if the underlying hypoxic insult was prolonged

3. Diagnostic Workup

Test	Role	Expected Findings
Chest X-ray	Best initial test	Coarse, irregular patchy infiltrates bilaterally; hyperinflation with flattened diaphragms; possible pneumothorax or pneumomediastinum
Arterial blood gas (ABG)	Assess severity	Hypoxemia ($PaO_2$ low), hypercarbia ($PaCO_2$ elevated), respiratory or mixed acidosis
Pulse oximetry (pre/post-ductal)	Screen for PPHN	Pre-ductal SpO2 higher than post-ductal by >5% indicates right-to-left ductal shunting
Echocardiography	Confirm PPHN, exclude structural heart disease	Elevated right ventricular pressure, tricuspid regurgitation, right-to-left shunting through PDA or PFO
Blood culture, CBC	Evaluate for sepsis/pneumonia	Obtained before empirical antibiotics; leukocytosis or bandemia may suggest secondary infection

The chest X-ray is the cornerstone of initial diagnosis. The hallmark finding is the combination of coarse, patchy bilateral infiltrates with hyperinflation. This pattern reflects the coexistence of atelectasis (from airway obstruction and surfactant inactivation) and air trapping (from the ball-valve mechanism). This is a crucial discriminator on examination: respiratory distress syndrome (RDS/hyaline membrane disease) shows diffuse, homogeneous ground-glass opacities with low lung volumes, which is the opposite pattern.

The CXR must also be carefully evaluated for air leak complications, particularly pneumothorax and pneumomediastinum, which occur in roughly 10 to 20 percent of MAS cases due to the overdistension of alveoli from the ball-valve mechanism. If a tension pneumothorax is suspected clinically (sudden deterioration with unilateral absent breath sounds and tracheal deviation), needle decompression must precede radiographic confirmation.

An ABG quantifies the degree of hypoxemia and guides ventilatory strategy. The oxygenation index (OI), calculated as:

$$OI = \frac{FiO_2 \times \overline{P}_{aw} \times 100}{PaO_2}$$

where $\overline{P}_{aw}$ is the mean airway pressure, is used to stratify severity and guide escalation to therapies such as inhaled nitric oxide (OI >25) or ECMO (OI >40 despite maximal therapy).

Pre-ductal and post-ductal pulse oximetry is a rapid, noninvasive screening tool for PPHN. The right hand (pre-ductal, supplied by vessels proximal to the ductus arteriosus) is compared with either foot (post-ductal). A difference of more than 5% strongly suggests right-to-left shunting through the ductus arteriosus, and echocardiography should follow to confirm PPHN and to exclude cyanotic congenital heart disease.

4. Management and Treatment

Phase	Intervention	Details
Delivery room	Initial resuscitation per current NRP guidelines	Do not perform routine tracheal suctioning. Begin standard initial steps (warmth, dry, stimulate). If non-vigorous, initiate PPV within the first minute. Intubate only for standard indications.
Mild disease	Supplemental oxygen	Warm, humidified oxygen via hood or nasal cannula; target SpO2 90-95%
Moderate disease	CPAP or mechanical ventilation	CPAP 5-8 cmH2O; transition to conventional mechanical ventilation if FiO2 requirement exceeds 60% or clinical worsening occurs
Severe disease	High-frequency oscillatory ventilation (HFOV)	Used when conventional ventilation fails; helps recruit atelectatic segments while minimizing barotrauma
Surfactant inactivation	Exogenous surfactant	Indicated for intubated infants requiring >50% FiO2; may require repeated doses
PPHN	Inhaled nitric oxide (iNO)	20 ppm initial dose; selective pulmonary vasodilator; initiated when OI >25
Refractory PPHN	ECMO	Considered when OI >40 despite iNO and optimal ventilation; requires gestational age >34 weeks and birth weight >2 kg
Infection prophylaxis	Empirical antibiotics	Ampicillin + gentamicin started after blood cultures; meconium predisposes to secondary infection
Supportive	Thermoregulation, fluid/electrolyte management, sedation	Neutral thermal environment; judicious IV fluids; minimal handling to avoid triggering pulmonary vasospasm

Delivery Room Management (Critical Update): The single most tested management point in MAS is the change in delivery room resuscitation guidelines. Prior to 2015, the standard teaching was to intubate and perform direct tracheal suctioning on all non-vigorous neonates born through meconium-stained amniotic fluid. Current guidelines (NRP 8th edition, 2020) no longer recommend routine endotracheal suctioning. The emphasis has shifted to initiating ventilation promptly. If the neonate is vigorous (strong respiratory effort, good muscle tone, heart rate >100 bpm), standard initial care is provided. If non-vigorous, positive pressure ventilation (PPV) is begun within the first 60 seconds. Intubation is performed only when standard indications arise, such as ineffective bag-mask ventilation or the need for prolonged ventilatory support. Oropharyngeal suctioning with a bulb syringe may be done if the airway appears obstructed by thick meconium, but this is not a routine step.

Respiratory Support Escalation: Management follows a stepwise escalation. Mild cases may only require supplemental oxygen. When oxygen requirements rise or work of breathing increases, CPAP is applied. Conventional mechanical ventilation with careful attention to avoiding excessive PEEP (to minimize further air trapping) is the next step. If ventilation fails or air leak syndromes develop, high-frequency oscillatory ventilation (HFOV) provides an alternative by using very small tidal volumes at rapid rates, which reduces the risk of barotrauma while maintaining adequate gas exchange.

Surfactant therapy is used when the infant is intubated with high oxygen requirements, reflecting surfactant inactivation by meconium. Bolus surfactant or dilute surfactant lavage has been studied, though the evidence more firmly supports bolus administration for improving oxygenation.

Inhaled nitric oxide (iNO) is the treatment for PPHN complicating MAS. As a selective pulmonary vasodilator, iNO relaxes the pulmonary vascular smooth muscle, reduces pulmonary artery pressure, and improves ventilation-perfusion matching. It is typically started at 20 ppm when the oxygenation index exceeds 25, and weaned gradually once oxygenation improves.

ECMO is reserved as a rescue therapy for neonates who remain hypoxemic despite maximal ventilatory support and iNO. Candidacy generally requires a gestational age of at least 34 weeks and a birth weight above 2 kg, and the absence of lethal anomalies or irreversible organ damage.

5. Differential Diagnosis and Distractors

Differential	Why It Is Similar	Key Discriminator
Transient tachypnea of the newborn (TTN)	Both cause tachypnea shortly after birth; both may show fluid in the lungs on CXR	TTN occurs in term/near-term infants (often after C-section without labor); CXR shows perihilar streaking and fluid in fissures with normal lung volumes, NOT patchy infiltrates with hyperinflation; TTN resolves within 24-72 hours with minimal support
Respiratory distress syndrome (RDS)	Both cause respiratory distress in neonates; both involve surfactant dysfunction	RDS is a disease of prematurity (<34 weeks) due to surfactant deficiency; CXR shows diffuse, homogeneous ground-glass opacities with low lung volumes and air bronchograms, the opposite of MAS which shows patchy infiltrates with hyperinflation
Neonatal pneumonia (Group B Streptococcus)	Both present with respiratory distress and abnormal CXR at birth; both may have systemic illness	Neonatal pneumonia is associated with maternal risk factors (prolonged rupture of membranes >18 hours, maternal fever, GBS colonization without prophylaxis); CXR may be indistinguishable, but the clinical context of maternal infection risk and positive blood/CSF cultures differentiates
Pneumothorax (primary)	Both cause acute respiratory distress with asymmetric findings	Primary pneumothorax shows unilateral absent breath sounds with hyperlucency on CXR; no meconium staining; note that pneumothorax can also be a complication of MAS
Congenital diaphragmatic hernia (CDH)	Both cause respiratory distress at birth with abnormal CXR	CDH presents with a scaphoid abdomen, bowel sounds in the chest, and CXR showing bowel loops in the thorax with mediastinal shift; no meconium staining history
Cyanotic congenital heart disease	Both can present with cyanosis refractory to supplemental oxygen	Cardiac cyanosis fails the hyperoxia test (PaO2 does not rise above 100 mmHg on 100% FiO2); echocardiography reveals structural anomaly; CXR may show abnormal cardiac silhouette rather than parenchymal disease

6. Traps and High-Yield Pearls

The most common way students lose points on MAS questions is by selecting routine endotracheal suctioning as the correct delivery room intervention for a non-vigorous neonate born through meconium-stained fluid. This was previously the standard of care but is no longer recommended. Current guidelines emphasize initiating positive pressure ventilation promptly rather than delaying resuscitation to suction the trachea. Expect the vignette to describe a limp, apneic, meconium-stained infant and ask for the "next best step." The answer is to begin PPV, not to intubate for suctioning.

A second common trap involves confusing the CXR pattern of MAS with that of RDS. The distinguishing principle is lung volume: MAS produces hyperinflation (flattened diaphragms, increased AP diameter), while RDS produces low lung volumes with diffuse ground-glass opacification. When a vignette describes a post-term infant with patchy infiltrates and hyperinflated lungs, the answer is MAS. When it describes a premature infant with uniform granular opacities and low volumes, the answer is RDS.

Third, students sometimes fail to recognize PPHN as a complication of MAS. If the vignette adds differential cyanosis (pre-ductal SpO2 higher than post-ductal) or refractory hypoxemia despite high FiO2, the question is testing your ability to identify superimposed PPHN and select inhaled nitric oxide as the next step.

Finally, remember the association with post-term pregnancy. The word "post-term" or "42 weeks" combined with meconium staining is a nearly pathognomonic vignette setup. The core competency tested is pattern recognition: linking gestational age, amniotic fluid character, CXR findings, and the updated resuscitation algorithm into a coherent clinical picture.

1e:["$","$L2d",null,{"article":{"id":"31e883a8-6296-45ca-bfaf-b1c8a4d1c9ca","title":"Meconium Aspiration Syndrome (MAS)","content":"$2e","category":"Respirologi","created_at":"2026-07-02T02:50:42.663719+00:00","status":"published","subcategory":null},"questionCount":0,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]